EUVIMEDEUVIMED entdecken
Crossref

Maintenance of Long-Term Effective Humoral Immune Response in Patients with COVID-19 with Homologous or Heterologous Booster Vaccines: A Retrospective Study

Xin Zhang iD, Li Li, Yongmei Liu, Haoting Zhan, Muwei Dai, Kun Zhang, Huimin Yan, Huixia Gao, Jingwen Liu, Shifu Liu, Weina Lu, Yongzhe Li und 3 weitere

Viral Immunology · 2024

DOI: 10.1089/vim.2024.0076 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viral Immunology, 2024. Verfasst von Xin Zhang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Disease, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, China. Hauptthemen laut MEDLINE: Immunization, Secondary, COVID-19, COVID-19 Vaccines, Antibodies, Viral. Die Arbeit nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunization, SecondaryCOVID-19COVID-19 VaccinesAntibodies, ViralImmunity, HumoralAntibodies, NeutralizingSARS-CoV-2HumansFemaleMiddle AgedMaleAdultRetrospective StudiesVaccines, InactivatedAgedVaccines, Subunit

Stichwörter der Autor:innen

COVID-19SARS-COV-2antibodiesheterologous booster vaccines

Substanzen

COVID-19 VaccinesAntibodies, ViralAntibodies, NeutralizingVaccines, InactivatedVaccines, Subunit

Autor:innen und Institutionen

  • Department of Infectious Disease, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
  • Department of Tuberculosis, The Fifth Hospital of Shijiazhuang, Hebei Medical University, Shijiazhuang, Hebei, China.
  • Department of Internal Medicine, Hebei Medical University, Shijiazhuang, Hebei, China.
  • Intensive Care Unit, The Fifth Hospital of Shijiazhuang, Hebei Medical University, Shijiazhuang, Hebei, China.
  • Department of Clinical Laboratory, State Key Laboratory of Complex, Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
  • Department of Orthopedics, The Fourth Hospital of Hebei Medical University and Hebei Cancer Hospital, Shijiazhuang, Hebei, China.

ORCID-Profile: Xin Zhang

Zitieren

APA

Zhang, X., Li, L., Liu, Y., Zhan, H., Dai, M., Zhang, K., Yan, H., Gao, H., Liu, J., Liu, S., Lu, W., Li, Y., Feng, A., Dai, E., & Zhou, J. (2024). Maintenance of Long-Term Effective Humoral Immune Response in Patients with COVID-19 with Homologous or Heterologous Booster Vaccines: A Retrospective Study. Viral Immunology. https://doi.org/10.1089/vim.2024.0076

Vancouver

Zhang X, Li L, Liu Y, Zhan H, Dai M, Zhang K, et al. Maintenance of Long-Term Effective Humoral Immune Response in Patients with COVID-19 with Homologous or Heterologous Booster Vaccines: A Retrospective Study. Viral Immunology. 2024. doi:10.1089/vim.2024.0076

BibTeX
@article{Zhang2024,
  author = {Zhang, Xin and Li, Li and Liu, Yongmei and Zhan, Haoting and Dai, Muwei and Zhang, Kun and Yan, Huimin and Gao, Huixia and Liu, Jingwen and Liu, Shifu and Lu, Weina and Li, Yongzhe and Feng, Aidong and Dai, Erhei and Zhou, Junying},
  title = {Maintenance of Long-Term Effective Humoral Immune Response in Patients with COVID-19 with Homologous or Heterologous Booster Vaccines: A Retrospective Study},
  journal = {Viral Immunology},
  year = {2024},
  doi = {10.1089/vim.2024.0076}
}
Kostenlos starten →